
Although considerable efforts have been made in the discovery of new agents for cancer treatment, several promising zzso cannot be applied zzso because of their severe side zzso This is the case for various zzso zzso zzso that, despite their potent zzso activity, can not find their way to clinical exploitation due to their devastating toxicity shown during dose escalation to zzso active zzso To circumvent these problems, an elegant and efficient way to accumulate therapeutic agents at the tumor site, thus reducing systemic side effects, is their zzso to zzso zzso Here, we review zzso data about zzso zzso to a promising zzso human zzso that selectively targets zzso zzso and blood vessels by binding with high affinity and specificity to the extra zzso zzso of zzso 

